Medtronic (NYSE: MDT) reported fourth quarter earnings that beat analyst estimates by $0.02. Revenue for the quarter came in at $8.5B, topping the consensus estimate of $8.25B. The company also provided guidance for FY 2024 EPS of $5.00-$5.10, versus the analyst consensus of $5.28. Medtronic’s stock price closed at $87.49, up 4.79% in the last 3 months and down -12.02% in the last 12 months.
InvestingPro’s Financial Health score for Medtronic is “good performance”. Investors can stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar.